Suppr超能文献

2002年美国透析相关疾病的全国监测

National surveillance of dialysis-associated diseases in the United States, 2002.

作者信息

Finelli Lyn, Miller Jeremy T, Tokars Jerome I, Alter Miriam J, Arduino Matthew J

机构信息

Epidemiology Branch, Division of Viral Hepatitis, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Department of Health and Human Services, Atlanta, Georgia 30333, USA.

出版信息

Semin Dial. 2005 Jan-Feb;18(1):52-61. doi: 10.1111/j.1525-139X.2005.18108.x.

Abstract

In December 2002, all U.S. chronic hemodialysis centers were surveyed regarding selected patient care practices and dialysis-associated diseases. The results were compared with similar surveys conducted in previous years. In 2002, 85% of hemodialysis centers were free-standing and 81% operated for profit; the proportion of centers operating for profit has increased each year since 1985. During 1995-2002, the percentage of patients who received dialysis through central catheters increased from 13% to 26%; this trend is worrisome, as infections and antimicrobial use are higher among patients receiving dialysis through catheters. However, during the same period, the percentage of patients receiving dialysis through fistulas increased from 22% to 33%. The percentage of centers reporting one or more patients infected or colonized with vancomycin-resistant enterococci (VRE) increased from 12% in 1995 to 30% in 2002. During 1997-2002, the percentage of patients vaccinated against hepatitis B virus (HBV) infection increased from 47% to 56% and the percentage of staff vaccinated increased from 87% to 90%. In 2002, routine testing for antibody to hepatitis C virus (anti-HCV) was performed on patients at 64% of centers; anti-HCV was found in 7.8% of patients. In 2001, the Centers for Disease Control (CDC) published Recommendations for Preventing Transmission of Infections among Chronic Hemodialysis Patients. Centers were surveyed regarding their awareness of the recommendations and about a variety of infection control practices. In general, the incidence of HBV and HCV was not substantially different for the infection control practices evaluated, including where staff obtain clean supplies for patient treatment, reuse of unused and unopened supplies, and practices for changing external transducer filters/protectors. However, in 2002, the incidence of HBV infection was higher among patients in centers where injectable medications were prepared on a medication cart or medication area located in the treatment area compared to a dedicated medication room. Also, those centers that used a disposable container versus a nondisposable container for priming the dialyzer had a significantly lower incidence of HCV.

摘要

2002年12月,针对选定的患者护理措施及与透析相关的疾病,对美国所有慢性血液透析中心进行了调查。将结果与前几年进行的类似调查进行了比较。2002年,85%的血液透析中心为独立机构,81%以盈利为目的运营;自1985年以来,盈利性运营中心的比例逐年增加。1995 - 2002年期间,通过中心静脉导管进行透析的患者比例从13%增至26%;这一趋势令人担忧,因为通过导管进行透析的患者感染及抗菌药物使用情况更为严重。然而,在同一时期,通过动静脉内瘘进行透析的患者比例从22%增至33%。报告有一名或多名患者感染或定植耐万古霉素肠球菌(VRE)的中心比例从1995年的12%增至2002年的30%。1997 - 2002年期间,接种乙型肝炎病毒(HBV)疫苗的患者比例从47%增至56%,接种疫苗的工作人员比例从87%增至90%。2002年,64%的中心对患者进行了丙型肝炎病毒抗体(抗-HCV)的常规检测;7.8%的患者检测出抗-HCV。2001年,疾病控制中心(CDC)发布了《预防慢性血液透析患者间感染传播的建议》。就各中心对这些建议的知晓情况以及各种感染控制措施进行了调查。总体而言,对于所评估的感染控制措施,包括工作人员为患者治疗获取清洁用品的地点、未使用和未开封用品的重复使用以及更换外部传感器过滤器/保护器的措施,HBV和HCV的发病率并无显著差异。然而,2002年,与专用配药室相比,在治疗区域的配药车或配药区配制注射用药物的中心,其患者中HBV感染的发病率更高。此外,使用一次性容器而非非一次性容器对透析器进行预充的中心,HCV的发病率显著更低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验